{
    "2021-05-06": [
        [
            {
                "time": "",
                "original_text": "湖南区域股市周报：总市值跌69亿 蓝思科技市值缩水115.38亿 连续下跌",
                "features": {
                    "keywords": [
                        "湖南",
                        "总市值",
                        "蓝思科技",
                        "市值缩水",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "东莞证券维持益丰药房推荐评级：Q1 利润同比大增，门店延续扩张",
                "features": {
                    "keywords": [
                        "东莞证券",
                        "益丰药房",
                        "Q1",
                        "利润同比大增",
                        "门店扩张"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年年报及2021年一季报总结：Q1业绩复苏回暖 看好CXO、疫苗、创新器械和服务等高景气板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2020年年报",
                        "2021年一季报",
                        "Q1业绩复苏",
                        "CXO",
                        "疫苗",
                        "创新器械",
                        "服务",
                        "高景气板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "东莞证券：益丰药房（603939.SH）2021Q1利润同比大增，维持“推荐”评级",
                "features": {
                    "keywords": [
                        "东莞证券",
                        "益丰药房",
                        "2021Q1",
                        "利润同比大增",
                        "推荐评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}